Association between the C957T polymorphism of the dopamine D2 receptor gene and schizophrenia
暂无分享,去创建一个
Jarmo Hietala | Terho Lehtimäki | Kari M. Mattila | T. Lehtimäki | J. Hietala | A. Illi | O. Kampman | E. Leinonen | K. Mattila | M. Hurme | Mikko Hurme | Heikki Katila | R. Rontu | K. Hänninen | H. Katila | S. Anttila | Kari Hänninen | Olli Kampman | Sami Anttila | Ari Illi | Riikka Rontu | Esa Leinonen
[1] P. McGuffin,et al. Genetic basis of schizophrenia , 1995, The Lancet.
[2] M. Laruelle. Dopamine Transmission in the Schizophrenic Brain , 2007 .
[3] J. Lieberman,et al. Association study of 12 polymorphisms spanning the dopamine D2 receptor gene and clozapine treatment response in two treatment refractory/intolerant populations , 2005, Psychopharmacology.
[4] Laurent Gouya,et al. The 3′ region of the DRD2 gene is involved in genetic susceptibility to schizophrenia , 2004, Schizophrenia Research.
[5] T. Lappalainen,et al. Regional differences among the Finns: a Y-chromosomal perspective. , 2006, Gene.
[6] R. V. Van Heertum,et al. Increased baseline occupancy of D2 receptors by dopamine in schizophrenia. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[7] N. Saitou,et al. Synonymous mutations in the human dopamine receptor D2 (DRD2) affect mRNA stability and synthesis of the receptor. , 2003, Human molecular genetics.
[8] J. Lieberman,et al. Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs , 2005, Molecular Psychiatry.
[9] K. Livak,et al. Allelic discrimination using fluorogenic probes and the 5' nuclease assay. , 1999, Genetic analysis : biomolecular engineering.
[10] T Foitzi,et al. Allelic discrimination using fluorogenic probes and the 5' nuclease assay , 1999 .
[11] P. Gorwood,et al. Association and excess of transmission of a DRD2 haplotype in a sample of French schizophrenic patients. , 2001, Schizophrenia Research.
[12] S. Faraone,et al. The Genetic Basis of Schizophrenia , 2004 .
[13] P. Sullivan,et al. Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies. , 2003, Archives of general psychiatry.
[14] K. Någren,et al. C957T polymorphism of the dopamine D2 receptor (DRD2) gene affects striatal DRD2 availability in vivo , 2004, Molecular Psychiatry.
[15] J. Lieberman. Dopamine Partial Agonists , 2004, CNS drugs.
[16] C. P. Morris,et al. The C/C genotype of the C957T polymorphism of the dopamine D2 receptor is associated with schizophrenia , 2005, Schizophrenia Research.